Ahmed Rabee | Biomedical Sciences | Best Research Article Award

Published on by Cell Biologist

Best Research Article Award

Ahmed Rabee
Sulaiman Alrajhi University, Saudi Arabia

Ahmed Rabee
Affiliation Sulaiman Alrajhi University
Country Saudi Arabia
Google Scholar ID KmgzUgEAAAAJ
Documents 3
Citations 5
h-index 1
Subject Area Biomedical Sciences
Event World Cell Biologist Awards

Ahmed Rabee is a biomedical sciences researcher affiliated with Sulaiman Alrajhi University in Saudi Arabia. Available scholarly profile information identifies a research record comprising three documents, five citations, and an h-index of 1. These indicators provide a concise bibliometric overview of the currently documented scholarly output associated with the researcher profile. [1]

Abstract

Ahmed Rabee is affiliated with Sulaiman Alrajhi University, Saudi Arabia, and is associated with the field of Biomedical Sciences. The available scholarly record lists three documents, five citations, and an h-index of 1. [1] This article presents a structured academic recognition profile describing the researcher’s affiliation, scholarly record, research contribution, publication profile, research impact, and suitability for consideration for the Best Research Article Award.

The assessment is framed around transparent academic recognition principles, including the relevance and quality of research outputs, scholarly contribution, documented impact, and the appropriate interpretation of bibliometric indicators. Responsible research assessment recommends that quantitative metrics be considered alongside qualitative evidence rather than treated as standalone measures of research quality. [2]

Keywords

Ahmed Rabee; Biomedical Sciences; Sulaiman Alrajhi University; Best Research Article Award; scientific research; biomedical research; scholarly publications; research impact; bibliometrics; academic recognition.

Introduction

Biomedical sciences encompass a broad range of research disciplines concerned with biological mechanisms, disease processes, diagnostics, therapeutics, prevention, and the translation of scientific knowledge into health-related applications. Within this environment, research articles serve as important vehicles for communicating experimental observations, analytical findings, methodological developments, and scientific interpretations.

Academic recognition of a research article generally requires consideration of the article’s scientific question, methodological rigor, originality, evidence base, clarity, relevance, and contribution to the field. Bibliometric indicators may provide supporting information regarding scholarly dissemination, although such indicators require contextual interpretation. The Leiden Manifesto emphasizes that research metrics should support expert assessment rather than replace it. [4]

Research Profile

Ahmed Rabee is associated with Sulaiman Alrajhi University in Saudi Arabia and works within the broad subject area of Biomedical Sciences. The researcher is represented in Google Scholar by the identifier KmgzUgEAAAAJ. The available profile records three scholarly documents, five citations, and an h-index of 1. [1]

The documented publication record should be interpreted as a snapshot of indexed scholarly activity rather than a complete representation of all research undertaken by the researcher. Differences in indexing coverage, author-name variants, publication types, and database update schedules can affect bibliometric profiles. For this reason, quantitative indicators are most appropriately evaluated together with the underlying publications and their scientific context. [4]

Research Contributions

The available information places Ahmed Rabee’s scholarly activity within Biomedical Sciences. The documented publication record provides evidence of participation in scholarly communication, while the associated citation count indicates that the indexed publications have received measurable scholarly attention. [1]

A detailed evaluation of individual research contributions should consider the scientific problem addressed, study design, experimental or computational methodology, validity of the evidence, reproducibility, interpretation of findings, and relevance to the biomedical research community. Principles for responsible research assessment emphasize the importance of combining quantitative information with qualitative expert judgment. [4]

Publications

The supplied scholarly profile records three documents associated with Ahmed Rabee. The available information does not provide the titles, journals, publication years, author lists, or DOI identifiers of those individual publications. Accordingly, this page does not assign publication-specific titles or research findings that have not been independently supplied or verified.

For scholarly articles, persistent identifiers such as Digital Object Identifiers (DOIs) provide stable mechanisms for identifying and linking research outputs. The DOI system is widely used to support persistent scholarly citation and discovery. [3]

Research Impact

The available profile records five citations for three documents, with an h-index of 1. [1] These figures indicate documented scholarly use or citation of the researcher’s indexed publications. However, citation counts can vary among databases and over time and should not be interpreted independently of publication age, disciplinary citation practices, collaboration patterns, and database coverage.

Research impact may also include qualitative dimensions such as methodological contribution, advancement of scientific understanding, educational value, contribution to clinical or public-health knowledge, collaboration, data availability, and subsequent development by other researchers. Responsible research evaluation therefore benefits from a multidimensional approach. [4]

Award Suitability

The Best Research Article Award is intended to recognize an individual research article demonstrating substantive academic merit. Based on the supplied information, Ahmed Rabee has a documented research profile in Biomedical Sciences and an indexed scholarly record comprising three documents, five citations, and an h-index of 1. [1]

Suitability for article-level recognition should ultimately be determined through assessment of the nominated publication itself. Relevant considerations may include originality, clarity of the research question, methodological rigor, validity of results, ethical and scientific standards,[4]

Conclusion

Ahmed Rabee is a researcher affiliated with Sulaiman Alrajhi University, Saudi Arabia, with a documented scholarly profile in Biomedical Sciences. The supplied Google Scholar record identifies three documents, five citations, and an h-index of 1. [1]

The Best Research Article Award provides an appropriate framework for recognizing research that demonstrates scientific quality, relevance, originality, and contribution to its field. Final article-level assessment should be based on direct examination of the nominated publication and supporting scholarly evidence rather than bibliometric indicators alone.

References

    1. Google Scholar. Ahmed Rabee ā€” Google Scholar author profile, Author ID KmgzUgEAAAAJ.
      https://scholar.google.com/citations?user=KmgzUgEAAAAJ&hl=en
    2. AR Rabee, M Gerges, et al. (2025). Photochromic spiroindolium iodide derivatives; synthesis, Molecular geometry DFT assessment and UVā€“vis photophysical investigation.
      https://www.sciencedirect.com/science/article/pii/S0022286025004260
    3. A Negm, AR Rabee, et al. (2025). Investigation of Quinoxaline-1,2,3-triazole Derivatives for Targeting SARS-CoV-2 via RBD Binding and PLpro Inhibition.
      https://link.springer.com/article/10.1134/S106816202460572X
    4. A Rabee, M Hamadan, et al. (2026). Advances in Exosome Engineering for Cardiovascular Applications.
      https://amb.cultechpub.com/amb/article/view/62

Junning Ma | Cell Surface Receptors | Best Research Article Award

Published on by Cell Biologist

Dr. Junning Ma | Cell Surface Receptors | Best Research Article Award

Zhejiang University | China

Dr. Junning Ma has developed a multidisciplinary portfolio spanning neurosurgery, neural engineering, biomaterials, and nanomedicine. Their work integrates neural stem cell biology, targeted drug delivery, and tumor microenvironment modulation to create innovative therapeutic strategies for brain diseases. They have conducted advanced postdoctoral and doctoral research at major institutions, contributing to National Natural Science Foundation of China (NSFC) Youth Fund projects and multiple US-funded NIH and AHA grants. Their research focuses on biomimetic nanocarriers, including cell membrane-coated nanoparticles, PLGA-based delivery systems, and fusion-membrane technologies designed for precision therapy of glioma, pituitary adenoma, and ischemic stroke.

Key projects include engineered neural stem cell membrane-coated nanoparticles for stroke targeting, biomimetic nanoplatforms for cancer immunotherapy, and tumor microenvironmentā€“responsive delivery systems. They have also contributed to studies on neuromodulation, neurotrophic factor-based therapy, neural stem cell transplantation, and photothrombotic stroke models. Their publication record includes high-impact journals such as Materials Today Bio, Biomaterials, Nano Letters, Small, and Cell Reports Physical Science, covering topics like vascular-targeting nanoclusters, polyphenol nanoparticles, and membrane-engineered carriers.

Overall, their research advances translational nanomedicine and regenerative neuroscience, with an emphasis on targeted therapies capable of overcoming the challenges of brain tumor heterogeneity, the bloodā€“brain barrier, and ischemic neural injury.

Profiles: Scopus | Orcid

Featured Publications:Ā 

Ma, J., Win, Y., Xiaojian, Z., et al. (2023). Enhanced EPR effects by folliculostellate cell membraneā€“coated nanoparticles on invasive pituitary adenoma. Materials Today Bio.

Ma, J., Dai, L., Jianbo, Y., et al. (2023). Tumor microenvironment targeting system for glioma treatment via fusion cell membrane coating nanotechnology. Biomaterials.

Ma, J., Liu, F., Wendy, C., et al. (2020). Co-presentation of tumor antigens with costimulation via biomimetic nanoparticles for effective cancer immunotherapy. Nano Letters.

Ma, J., Zhang, S., Jun, L., et al. (2019). Targeted drug delivery to stroke via chemotactic recruitment of nanoparticles coated with membranes of engineered neural stem cells. Small.

Wan Wan Lin | Inflammation | Best Researcher Award

Published on by Cell Biologist

Prof. Wan Wan Lin | Inflammation | Best Researcher Award

Department of Pharmacology, College of Medicine, NTU | Taiwan

Dr. Wan-Wan Lin is a leading researcher in the fields of pharmacology and immunology, with a strong focus on cellular signaling and innate immune mechanisms. Her work has significantly advanced understanding of signal transduction pathways and their regulation of inflammation and cell death. She has made notable contributions to the study of pattern recognition receptors, inflammasomes, and cytokine-mediated immune responses, particularly in the context of oxidative stress and mitochondrial function. Dr. Linā€™s research explores how mitochondrial dynamics and redox balance influence inflammatory signaling and programmed cell death, providing key insights into the molecular basis of immune regulation and inflammatory diseases. Her studies have also shed light on the crosstalk between cellular stress responses and immune activation, offering potential therapeutic targets for controlling excessive inflammation and tissue damage. Recognized for her excellence in research, Dr. Lin has received multiple national awards and continues to contribute to the advancement of pharmacological sciences through her editorial and academic roles. Her integrative approach bridges pharmacology, immunology, and cell biology, driving innovations in the understanding of molecular mechanisms underlying inflammation and innate immunity.

Profile: Orcid

Featured Publications:

Lin, W.-W., Lee, C.-Y., Tsai, M.-C., & Tsaur, M.-L. (1985). Pharmacological study on angusticeps-type toxins from mamba snake venoms. Journal of Pharmacology and Experimental Therapeutics, 233, 491ā€“498.

Lin, W.-W., Chang, P.-L., Lee, C.-Y., & Joubert, F. J. (1987). Pharmacological study on phospholipases Aā‚‚ isolated from Naja mossambica mossambica venom. Proceedings of the National Science Council, Republic of China B, 11, 155ā€“163.

Lin, W.-W., Lee, C.-Y., & Burnett, J. W. (1988). Effect of sea nettle (Chrysaora quinquecirrha) venom on isolated rat aorta. Toxicon, 26, 1209ā€“1212.

Chiou, S.-H., Lin, W.-W., & Chang, W.-P. (1989). Sequence characterization of venom toxins from Thailand cobra. International Journal of Peptide and Protein Research, 34, 148ā€“152.

Lee, C.-Y., Lin, W.-W., Chen, Y.-M., & Lee, S.-Y. (1989). Is direct cardiotoxicity the primary cause of death following intravenous injection of the basic phospholipase Aā‚‚ from Naja nigricollis venom? Acta Physiologica et Pharmacologica Latinoamericana, 39, 383ā€“391.

Lee, C.-Y., & Lin, W.-W. (1989). Two subtypes of acetylcholinesterase isoenzymes distinguishable by Angusticeps-type toxin F7. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology and Toxicology, 92, 279ā€“281.

Lin, W.-W., Lee, C.-Y., & Chuang, D.-M. (1989). Cross-desensitization of endothelin- and sarafotoxin-induced phosphoinositide turnover in neurons. European Journal of Pharmacology, 166, 581ā€“582.

Lin, W.-W., Chen, Y.-M., Lee, S.-Y., Nishio, H., Kimura, T., Sakakibara, S., & Lee, C.-Y. (1990). Cardiovascular effects of two disulfide analogues of sarafotoxin S6b. Toxicon, 28, 911ā€“923.

Lin, W.-W., Lee, C.-Y., Yasumoto, T., & Chuang, D.-M. (1990). Maitotoxin induces phosphoinositide turnover and modulates glutamatergic and muscarinic cholinergic receptor function in cultured cerebellar neurons. Journal of Neurochemistry, 55, 1563ā€“1568.

Lin, W.-W., & Lee, C.-Y. (1990). Biphasic effects of endothelin in the guinea-pig ileum. European Journal of Pharmacology, 176, 57ā€“62.

Rosa M Giraldez-Perez | Intracellular Transport Systems | Innovative Research Award

Published on by Cell Biologist

Prof. Dr. Rosa M Giraldez-Perez | Intracellular Transport Systems | Innovative Research Award

University or Cordoba | Spain

Rosa Marƭa GirƔldez-PƩrez is a researcher in the fields of nanotechnology, nanomedicine, physiology, and neuroscience whose scientific contributions focus on the design and application of nanomaterials for therapeutic purposes. Her work has addressed innovative strategies such as gold nanosystems functionalized with antibiotics or anticancer drugs, the development of nanocarriers for leukemia, prostate, liver, and lung cancer treatments, as well as nanoparticle-based approaches to prevent antibiotic resistance. She has also contributed to research in obesity therapy through nanosystems targeting metabolic regulation and in neuroscience through studies on oxidative stress and fragile X syndrome. Her research output includes 81 scientific documents, which have accumulated 911 citations and reflect an h-index of 13, demonstrating both productivity and impact in her field. A significant portion of her publications are in high-impact journals indexed in the Journal Citation Reports (JCR), and several list her as first or senior author, highlighting her leading role in collaborative projects. By integrating expertise from cellular biology, physiology, and nanoscience, her work advances translational biomedical research and offers potential therapeutic solutions for cancer, infectious diseases, metabolic disorders, and neurological conditions.

Profiles: Orcid | Scopus

Featured Publications:

GirƔldez-PƩrez, R. M., Grueso, E. M., Montero-Hidalgo, A. J., Muriana-FernƔndez, C., Kuliszewska, E., Luque, R. M., & Prado-Gotor, R. (2025). Daunomycin nanocarriers with high therapeutic payload for the treatment of childhood leukemia. Pharmaceutics, 17(9), 1236.

De Diego-Otero, Y., El Bekay, R., Garcƭa-Guirado, F., SƔnchez-Salido, L., & GirƔldez-PƩrez, R. M. (2024). Apocynin, a selective NADPH oxidase (Nox2) inhibitor, ameliorates behavioural and learning deficits in the fragile X syndrome mouse model. Biomedicines, 12(2887).

Lhamyani, S., Gentile, A. M., Mengual-Mesa, M., Grueso, E., GirĆ”ldez-PĆ©rez, R. M., Fernandez-Garcia, J. C., ā€¦ El Bekay, R. (2024). Au@16-pH-16/miR-21 mimic nanosystem: An efficient treatment for obesity through browning and thermogenesis induction. Biomedicine & Pharmacotherapy, 171, 116104.

GirƔldez-PƩrez, R. M., Grueso-Molina, E. M., Carbonero-Martƭnez, A., ƁlvarezmƔrquez, J., Kuliszewska, E., Gordillo-Macƭas, M., & Prado-Gotor, R. (2023). Synergistic antibacterial effects of amoxicillin and gold nanoparticles: A therapeutic option to combat antibiotic resistance. Antibiotics, 12(8), 81275.

GirƔldez-PƩrez, R. M., Grueso, E., Montero-Hidalgo, A. J., Luque, R. M., Carnerero, J. M., Kuliszewska, E., & Prado-Gotor, R. (2022). Gold nanosystems covered with doxorubicin/DNA complexes: A therapeutic target for prostate and liver cancer. International Journal of Molecular Sciences, 23(24), 15575.

GirƔldez-PƩrez, R. M., Grueso, E. M., JimƩnez-Aguayo, R., Carbonero, A., GonzƔlez-Bravo, M., Kuliszewska, E., & Prado-Gotor, R. (2022). Use of nanoparticles to prevent resistance to antibiotics: Synthesis and characterization of gold nanosystems based on tetracycline. Pharmaceutics, 14(9), 1941.

Lhamyani, S., Gentile, A. M., GirĆ”ldez-PĆ©rez, R. M., et al. (2021). miR-21 mimic blocks obesity in mice: A novel therapeutic option. Molecular Therapy ā€“ Nucleic Acids, 26, 401ā€“416. h

Grueso-Molina, E. M., GirƔldez-PƩrez, R. M., Kuliszewska, E., Guerrero, J. A., & Prado-Gotor, R. (2021). Reversible cationic gemini surfactant-induced aggregation of anionic gold nanoparticles for sensing biomolecules. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 610, 125893.

Gomes, A., Carnerero-Panduro, J. M., JimƩnez-Ruiz, A., Grueso-Molina, E. M., GirƔldez-PƩrez, R. M., & Prado-Gotor, R. (2021). Lysozyme-AuNPs interactions: Determination of binding free energy. Nanomaterials, 11(8), 2139.

GirƔldez-PƩrez, R. M., Grueso-Molina, E. M., Domƭnguez-Garcƭa, I., Pastor-Carrillo, N. M., Kuliszewska, E., & Prado-Gotor, R. (2021). Biocompatible DNA/5-fluorouracil gemini surfactant-functionalized gold nanoparticles as promising vectors in lung cancer therapy. Pharmaceutics, 13(3), 423.

Song He | Tissue Engineering Regeneration | Best Researcher Award

Published on by Cell Biologist

Dr. Song He | Tissue Engineering Regeneration | Best Researcher Award

Dr. Song He, Hunan University of Humanities, Science and Technology, China

Dr. Song He is a dedicated researcher and lecturer at the School of Energy and Mechanical Engineering, Hunan University of Humanities, Science and Technology. With a strong background in civil materials and energy systems, Dr. He has made impactful contributions in the field of nanoporous aluminum substrates, heat transfer mechanisms, and condensation processes. His research bridges fundamental science and engineering applications, particularly in energy efficiency and materials performance. As a first author on multiple high-impact publications and an inventor on several patents, he has demonstrated both technical depth and innovation. Dr. Heā€™s work is recognized for addressing real-world challenges in sustainable cooling and energy systems. His career path reflects consistent academic growth from undergraduate studies through to a PhD, followed by impactful research and teaching contributions. Passionate about material science and thermal dynamics, Dr. He exemplifies the qualities of a next-generation scientific leader.

PublicationĀ  Profile:

Orcid

āœ… Strengths for the Award:

  1. Strong Publication Record (First Author & Peer-Reviewed)

    • Multiple first-author journal articles in internationally recognized journals like Materials, Applied Sciences, Energies, and Journal of Materials Research and Technology.

    • Research is focused on high-impact, emerging areas like nanoporous aluminum substrates, solar thermal applications, and frosting mechanisms.

  2. Innovation and Practical Contribution

    • Holder of three patents related to testing devices for heat transfer and solar radiation absorption of aluminum materials, showing real-world application of research.

  3. Specialization in Sustainability and Energy Efficiency

    • Research closely aligns with modern needs for sustainable cities, renewable energy, and climate-adaptive cooling technologies.

    • Topics such as interface condensation, solar absorption, and surface coatings are directly relevant to global energy challenges.

  4. Long-Term Academic and Research Dedication

    • Strong academic background (BEng + PhD) and a consistent career trajectory.

    • Lecturer since 2020, actively involved in both teaching and applied research.

šŸ”§ Areas for Improvement:

  1. Broader International Engagement Needed

    • Limited visibility in international conferences, workshops, and global collaborative projects.

    • Increasing participation in international academic communities would enhance both recognition and impact.

  2. Publication Impact and Journal Tier

    • While the journals are respectable, publishing in top-tier (Q1) journals like Advanced Materials, Nano Energy, or Energy & Environmental Science could elevate the scientific profile.

  3. Postdoctoral or International Fellowships

    • No postdoctoral experience or overseas academic training mentioned.

    • Pursuing a global postdoctoral opportunity would enhance expertise and network.

šŸŽ“ Education:

Dr. Song He holds a Ph.D. in Civil Materials and Engineering from Guangdong University of Technology (2015ā€“2020), where his research focused on advanced thermal interface materials and nanoporous substrates. Prior to this, he completed his Bachelorā€™s degree in Building Environment and Equipment Engineering at Hunan University of Technology (2011ā€“2015), laying the foundation for his interest in energy systems and materials performance. His academic training included interdisciplinary exposure to heat exchange technologies, solar energy applications, and environmental materials, combining theory with hands-on experimentation. Through his doctoral studies, Dr. He developed expertise in micro/nanoporous materials, surface treatments, and condensation properties critical to energy efficiency systems. His strong academic record and progression reflect his commitment to high-impact research and continuous learning. Dr. He’s educational background has prepared him to lead and innovate in the domains of thermal sciences, sustainable technologies, and energy-efficient materials.

šŸ’¼ Experience:

Since December 2020, Dr. Song He has been a lecturer at the School of Energy and Mechanical Engineering, Hunan University of Humanities, Science and Technology. His teaching and research focus on material science, energy engineering, and surface phenomena. Prior to this, he completed his Ph.D. at Guangdong University of Technology, where he was actively involved in national and regional research projects. Dr. He has collaborated with notable researchers, contributed to interdisciplinary research teams, and co-authored several scientific papers. His hands-on experience includes the development and testing of novel nanoporous aluminum sheets for thermal applications. He has also contributed to the design and patenting of specialized testing devices for thermal and frosting properties. With a blend of academic and experimental work, Dr. He has developed deep knowledge in sustainable materials and surface engineering. His career showcases a balance of scientific inquiry, practical innovation, and educational contribution.

šŸ”¬ Research Focus:

Dr. Song Heā€™s research centers on the thermal and surface properties of nanoporous aluminum materials and their applications in energy-efficient systems. His work explores the interface effects, condensation characteristics, solar absorption, and frosting mechanisms of micro/nanostructured materials. A significant part of his research focuses on improving heat exchanger efficiency, air-conditioning performance, and solar thermal energy capture through material innovation. He has studied the role of hygroscopic coatings and nanoporous substrates in enhancing thermal transfer and minimizing frost formation. Dr. He also investigates material-environment interactions, including moisture absorption and radiation management, to support sustainable building technologies. His patented devices offer novel methods for testing aluminum sheets under various environmental conditions. His work bridges fundamental surface physics with real-world energy applications, addressing critical needs in sustainable cities, green energy systems, and advanced thermal technologies. His focus positions him at the intersection of materials innovation and energy efficiency.

šŸ“š Publications Top Notes:

  1. šŸ“˜ Investigation of the Interface Characteristics and Frosting Properties of the Nanoporous Alumina Sheets ā€“ Journal of Materials Research and Technology, 2025

  2. šŸ”¬ Review of Hygroscopic Coating on Aluminum Fin Surface of Air Conditioning Heat Exchanger ā€“ Applied Sciences, 2021

  3. šŸŒž Investigation on the Solar Absorption Property of the Nanoporous Alumina Sheet for Solar Application ā€“ Materials, 2019

  4. ā„ļø Effects and Frosting Mechanism of Nanoporous Alumina Sheets ā€“ Energies, 2023

  5. šŸ§Ŗ Investigation of the Interface Effects and Condensation Properties of the Micro/Nanoporous Aluminum Plates ā€“ Sustainable Cities and Society, (Date unspecified)

šŸ“Œ Conclusion:

Dr. Song He is a highly promising candidate for the Best Researcher Award, especially for his contributions to nanomaterials, surface engineering, and sustainable energy applications. He brings a combination of academic rigor, innovation, and application-driven research that addresses critical energy and environmental challenges.

Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Published on by Cell Biologist

Dr. Lingyan Zhou | Cell Death Pathway | Best Researcher Award

Dr. Lingyan Zhou , Shandong Provincial Hospital Affiliated to Shandong First Medical University , China

Dr. Lingyan Zhou is a dedicated neuroscientist and clinician specializing in the pathogenesis of neurodegenerative diseases, including Alzheimerā€™s and Parkinsonā€™s disease. Currently serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, Dr. Zhou holds a doctorate and has made notable contributions to neurodegeneration research through high-impact publications and cutting-edge studies. Her work focuses on molecular mechanisms such as protein aggregation, homocysteinylation, and neuroprotection, with particular attention to Ī±-synuclein and DJ-1. Dr. Zhou has co-authored more than 15 peer-reviewed articles in top-tier journals like Nature Communications, Science Advances, and Aging Cell, earning recognition for her insights into disease-modifying pathways. A researcher with a strong translational focus, she bridges the gap between bench and bedside, aiming to develop therapeutic strategies that can mitigate or reverse neurodegenerative processes. Her commitment to science and patient-centered research makes her a strong candidate for the Best Researcher Award.

Publication Profile:

Orcid

āœ… Strengths for the Award:

  1. Strong Publication Record in High-Impact Journals
    Dr. Zhou has consistently published in top-tier journals such as Nature Communications, Science Advances, Aging Cell, and Movement Disorders, reflecting the significance and innovation of her work. Many of these are Q1 journals with high impact factors.

  2. Focused Research on Neurodegeneration
    Her core focus on the molecular basis of Alzheimer’s and Parkinsonā€™s disease, especially novel mechanisms like N-homocysteinylation, STAT1-PARP1, and microRNA signaling, demonstrates depth and relevance to global health priorities.

  3. Translational Impact
    Her research bridges basic science and clinical application, particularly through studies on neuroprotection, early disease biomarkers, and potential therapeutic targets.

  4. Early Career Excellence
    Despite being in the early stages of her career, Dr. Zhou has already authored or co-authored over 17 peer-reviewed publications, many as first or corresponding author, which is exceptional at this stage.

  5. Multidisciplinary Collaborations
    Dr. Zhouā€™s collaborations with experts across genetics, immunology, bioinformatics, and neurology highlight her integrative approach to complex diseases.

  6. International Visibility
    Multiple articles are indexed in PubMed, Crossref, and DOIs, showing her research has international academic presence and reach.

āš ļø Areas for Improvement:

  1. Greater International Exposure
    While her publication record is strong, further participation in international neuroscience conferences, workshops, or global consortia would enhance visibility and foster leadership roles.

  2. Grant Leadership and Independent Funding
    As she progresses, securing independent research funding and leading grant-funded projects will further demonstrate research independence and strengthen her candidacy for top-tier awards.

  3. Mentorship and Teaching Roles
    Involvement in structured mentorship or supervision of Ph.D./postdoctoral researchers could be better highlighted to show contributions to research training and capacity building.

  4. Innovation Translation Pathway
    Filing patents or initiating translational collaborations with biotech/pharma could underline the practical applicability of her findings.

šŸŽ“ Education:

Dr. Lingyan Zhou received her doctorate from Wuhan University, one of Chinaā€™s leading research institutions, between September 2020 and June 2023. During her Ph.D. training, she developed expertise in molecular neuroscience and translational medicine, with a specific focus on the pathological mechanisms underlying Parkinsonā€™s and Alzheimerā€™s diseases. Her research explored cellular stress pathways, protein misfolding, and epigenetic regulation in neurodegeneration, leading to multiple first-author publications in high-impact journals. Her academic background provided a solid foundation in experimental techniques such as immunohistochemistry, gene expression analysis, and in vivo disease modeling. The interdisciplinary approach at Wuhan University enriched her understanding of both clinical neurology and basic neuroscience. This rigorous academic training has equipped Dr. Zhou with the analytical and research skills necessary for advancing innovation in neurodegenerative disease treatment.

šŸ§Ŗ Experience:

Since July 2023, Dr. Lingyan Zhou has been serving in the Department of Neurology at Shandong Provincial Hospital affiliated with Shandong First Medical University, where she engages in both clinical practice and translational neuroscience research. Prior to that, she completed her doctoral studies at Wuhan University, where she developed a deep interest in the role of homocysteine metabolism and genetic regulation in Parkinsonā€™s disease. Over her career, she has collaborated with multidisciplinary teams to investigate molecular and cellular mechanisms of neurodegeneration and published extensively in internationally recognized journals. Her current position allows her to continue high-impact research while mentoring junior colleagues and participating in multi-center studies. Her combined experience in basic research, clinical neurology, and academic collaboration has established her as a key contributor in the field of neurodegenerative diseases, positioning her well for leadership roles and research recognition such as the Best Researcher Award.

šŸ§  Research Focus:

Dr. Lingyan Zhouā€™s research is centered on understanding the molecular and cellular mechanisms that drive neurodegenerative diseases, with an emphasis on Alzheimerā€™s and Parkinsonā€™s disease. Her work has shed light on pathological protein modifications, such as N-homocysteinylation of Ī±-synuclein and DJ-1, which contribute to protein aggregation and neurotoxicity. Additionally, she investigates the neuroprotective roles of vitamins, retinoic acid, and microRNAs in slowing disease progression. Dr. Zhou is also exploring how infectious diseases like SARS-CoV-2 may trigger or exacerbate neurological disorders, expanding the understanding of systemic factors in brain health. Her studies leverage both in vitro and in vivo models to unravel pathways involving STAT1, PARP1, and Notch signaling. By identifying potential therapeutic targets and biomarkers, her research aims to guide the development of novel treatment strategies that could improve outcomes for patients suffering from movement disorders and cognitive decline.

šŸ“š Publications Top Notes:

  1. šŸ§Ŗ N-homocysteinylation of alpha-synuclein promotes its aggregation and neurotoxicity ā€“ Aging Cell (2022)

  2. šŸ§  Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study ā€“ J Transl Med (2023)

  3. šŸ§¬ Homocysteine and Parkinson’s disease ā€“ CNS Neurosci Ther (2023)

  4. šŸ§“ Retinoic Acid Prevents alpha-Synuclein Preformed Fibrils-Induced Toxicity via Inhibiting STAT1-PARP1 Signaling ā€“ Mol Neurobiol (2023)

  5. šŸ§« N-homocysteinylation of DJ-1 promotes neurodegeneration in Parkinson’s disease ā€“ Aging Cell (2024)

  6. šŸ¦  SARS-CoV-2: Underestimated damage to nervous system ā€“ Travel Med Infect Dis (2020)

  7. šŸ’Š Potential therapeutic drugs for ischemic stroke based on bioinformatics analysis ā€“ Int J Neurosci (2019)

  8. šŸ§¬ PTPN22 Gene Polymorphisms and Stroke Susceptibility ā€“ Dis Markers (2019)

  9. šŸ§Ŗ IL-18 Gene Polymorphisms and Risk of Ischemic Stroke: A Meta-analysis ā€“ Neuroreport (2019)

  10. šŸš¬ Aromatic hydrocarbon receptor links smoking and rheumatoid arthritis ā€“ Clin Exp Rheumatol (2020)

šŸ§¾ Conclusion:

Dr. Lingyan Zhou demonstrates an exceptional trajectory for a young neuroscience researcher. Her deep and original contributions to unraveling molecular mechanisms in neurodegeneration, particularly Parkinson’s and Alzheimer’s disease, make her highly deserving of recognition. The breadth and quality of her publication recordā€”combined with her translational outlookā€”signal a rising star in neurodegenerative disease research.